BioSpace News Archive

T2 Biosystems, Inc. (NASDAQ:TTOO), a global leader in the rapid detection of sepsis-causing pathogens, today announced that its Board of Directors has appointed Aparna Ahuja, MD, as Chief Medical Officer (CMO), effective immediately.

Meridian Bioscience, Inc. (NASDAQ: VIVO) a provider of diagnostic testing solutions and life science raw materials, announced preliminary financial results for the first quarter of fiscal 2021.

Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases, today announced that Steven Nichtberger, M.D., President and Chief Executive Officer, will present at the 39th Annual J.P. Morgan Healthcare Conference on January 14, 2021 at 5:20 p.m. ET. A live webcast of the presentation will be available on t

Praxis Precision Medicines, Inc. (NASDAQ: PRAX), today announced that the U.S. Food and Drug Administration (FDA) has granted both rare pediatric disease and orphan drug designations for PRAX-222 for the treatment of SCN2A developmental and epileptic encephalopathy (SCN2A-DEE).

Konica Minolta Healthcare Americas Inc. and strategic partner AGIMED, a leading healthcare distributor in Argentina, jointly announce the implementation of Konica Minolta imaging management solutions across the primary public health hospital system in Córdoba, Argentina’s second largest region.

Micron Medical, a privately-held medical device company engaged in the development, manufacture and early stage commercialization of innovative wireless, minimally invasive, electroceutical solutions for urological conditions, focused on OAB, published a letter to shareholders.

Economic activity in the services sector grew in December for the seventh month in a row, say the nation’s purchasing and supply executives in the latest Services ISM® Report On Business®.

Talton will lead the development of a new vision and strategy to advance diversity, equity and inclusion at the independent biomedical research and treatment center

ProPath, the largest fully physician-owned pathology practice in the United States, today announced that Julia A. Bridge, M.D., a board-certified pathologist and geneticist with an extensive medical career and expertise in solid tumor molecular testing, has joined the ProPath team.

Pharmacy Times®, the leading multimedia resource for pharmacy professionals, adds the Association of Community Cancer Centers to its Strategic Alliance Partnership program.